tetano
Editor, Senior Moderator
Diabetes Res Clin Pract
. 2020 Sep 23;108467.
doi: 10.1016/j.diabres.2020.108467. Online ahead of print.
Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran
Mostafa Akbariqomi[SUP] 1 [/SUP], Mahboobeh Sadat Hosseini[SUP] 2 [/SUP], Jamal Rashidiani[SUP] 3 [/SUP], Hamid Sedighian[SUP] 4 [/SUP], Hossein Biganeh[SUP] 5 [/SUP], Reza Heidari[SUP] 6 [/SUP], Mehrdad Moosazadeh Moghaddam[SUP] 7 [/SUP], Gholamreza Farnoosh[SUP] 8 [/SUP], Hamid Kooshki[SUP] 9 [/SUP]
Affiliations
Abstract
Aim: To describe the epidemiological and clinical characteristics along with outcomes of hospitalized Coronavirus Disease 2019 (COVID-19) patients with and without diabetes.
Methods: This retrospective, single-center study included 595 consecutive hospitalized patients with confirmed COVID-19 at Baqiyatallah Hospital in Tehran, Iran, from February 26, 2020 to March 26, 2020. Demographic data, clinical, laboratory, and radiological findings were collected and compared between patients based on diabetes status. Complications and clinical outcomes were followed up until April 4, 2020.
Results: From among the 595 hospitalized patients with COVID-19, the median age was 55 years and 401 (67.4%) were male. The most common symptoms included fever (419 [70.4%]), dry cough (368 [61.8%]) and dyspnea (363 [61%]). A total of 148 patients (24.9%) had diabetes, and compared with patients without diabetes, these patients had more comorbidities (eg, hypertension [48.6% vs. 22.3%; P <.001]); had higher levels of white blood cell count, neutrophil count, C-reactive protein, erythrocyte sedimentation rate and blood urea nitrogen, and had a higher proportion of patchy ground-glass opacity in chest computed tomography findings (52.7% vs. 25.7%; P <.001). Significantly, patients with diabetes had more complications and needed more respiratory support than those without diabetes (P <.001). At the end of the follow-up, treatment failure and death was significantly higher in patients with diabetes compared to those without diabetes (17.8% vs. 8.7%; P = 0.003).
Conclusion: COVID-19 patients with diabetes are at a higher risk of complications and a higher in-hospital mortality during hospitalization. Diabetes status of COVID-19 patients and frequent monitoring of glycemia would be helpful to prevent deteriorating clinical conditions.
Keywords: COVID-19; Clinical Characteristics; Diabetes; Hospitalized.
. 2020 Sep 23;108467.
doi: 10.1016/j.diabres.2020.108467. Online ahead of print.
Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran
Mostafa Akbariqomi[SUP] 1 [/SUP], Mahboobeh Sadat Hosseini[SUP] 2 [/SUP], Jamal Rashidiani[SUP] 3 [/SUP], Hamid Sedighian[SUP] 4 [/SUP], Hossein Biganeh[SUP] 5 [/SUP], Reza Heidari[SUP] 6 [/SUP], Mehrdad Moosazadeh Moghaddam[SUP] 7 [/SUP], Gholamreza Farnoosh[SUP] 8 [/SUP], Hamid Kooshki[SUP] 9 [/SUP]
Affiliations
- PMID: 32979419
- DOI: 10.1016/j.diabres.2020.108467
Abstract
Aim: To describe the epidemiological and clinical characteristics along with outcomes of hospitalized Coronavirus Disease 2019 (COVID-19) patients with and without diabetes.
Methods: This retrospective, single-center study included 595 consecutive hospitalized patients with confirmed COVID-19 at Baqiyatallah Hospital in Tehran, Iran, from February 26, 2020 to March 26, 2020. Demographic data, clinical, laboratory, and radiological findings were collected and compared between patients based on diabetes status. Complications and clinical outcomes were followed up until April 4, 2020.
Results: From among the 595 hospitalized patients with COVID-19, the median age was 55 years and 401 (67.4%) were male. The most common symptoms included fever (419 [70.4%]), dry cough (368 [61.8%]) and dyspnea (363 [61%]). A total of 148 patients (24.9%) had diabetes, and compared with patients without diabetes, these patients had more comorbidities (eg, hypertension [48.6% vs. 22.3%; P <.001]); had higher levels of white blood cell count, neutrophil count, C-reactive protein, erythrocyte sedimentation rate and blood urea nitrogen, and had a higher proportion of patchy ground-glass opacity in chest computed tomography findings (52.7% vs. 25.7%; P <.001). Significantly, patients with diabetes had more complications and needed more respiratory support than those without diabetes (P <.001). At the end of the follow-up, treatment failure and death was significantly higher in patients with diabetes compared to those without diabetes (17.8% vs. 8.7%; P = 0.003).
Conclusion: COVID-19 patients with diabetes are at a higher risk of complications and a higher in-hospital mortality during hospitalization. Diabetes status of COVID-19 patients and frequent monitoring of glycemia would be helpful to prevent deteriorating clinical conditions.
Keywords: COVID-19; Clinical Characteristics; Diabetes; Hospitalized.